Christos Argyropoulos is a Nephrology physician affiliated with University of New Mexico. OpenAlex indexes 171 publications with 2,980 citations (h-index 31); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2211 Lomas Blvd NE
Albuquerque, NM 871062719
Telephone
505-272-4750Provider last certified this registry record 12 Dec 2024.
Clinical trials
- Quality of Life in Greek Hemodialysis Patients Receiving Zemplar Intravenous
Sponsor: AbbVie (prior sponsor, Abbott)
- Paricalcitol Oral Therapy in Predialysis CKD Patients. The Greek Experience
Sponsor: AbbVie (prior sponsor, Abbott)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Bayer Healthcare Pharmaceuticals Inc.Program year20253 payments
- Grifols Shared Services North America, Inc.Program year20241 payment
- IDORSIA PHARMACEUTICALS US INCProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
54.1%Calcium channel blocker13.2%Amlodipine Besylate60%Nifedipine Er40%Part D≥19 patientsLoop diuretic7.3%Furosemide74%Torsemide27%Part D<11 patients+ 7 more classes in this area
Metabolism & gastrointestinal
26.6%SGLT2 inhibitor8.1%Jardiance61%Farxiga39%Part D<11 patientsCorticosteroid5.7%Prednisone100%Part D≥16 patients+ 4 more classes in this area
Genitourinary & hormones
5.5%alpha-Adrenergic Blocker3.3%Tamsulosin Hcl100%Part D<11 patients5-alpha Reductase Inhibitor2.2%Finasteride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pseudohyponatremia: Mechanism, Diagnosis, Clinical Associations and Management
Journal of Clinical Medicine
2023 - Moving from Evidence to Implementation of Breakthrough Therapies for Diabetic Kidney Disease
Clinical Journal of the American Society of Nephrology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Corey Ford, MD
University of New Mexico
Andrew Matsumoto, MD
University of New Mexico
Denise Lin, MD
University of New Mexico
Mauricio Tohen, MD, DRPH, MBA
University of New Mexico
Andrew Levey, MD
Tufts Medical Center
Glenn M. Chertow
FIND
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”